Neisseria gonorrhoea testing in New Zealand, culture or PCR?

New Zealand Journal of Medical Laboratory Science

Volumn 67, Issue 1, 2013, Pages 4-6

  Bromhead, Collette ^a   Miller, Amanda ^a   Jones, Mark ^a,b  

^a Molecular Biology Department   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Gonorrhoea; Neisseria gonorrhoeae; New Zealand; Polymerase chain reaction; PorA opa supplementary testing; Sputasol; Testing trends

Indexed keywords

RNA 16S;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CONFORMATIONAL TRANSITION; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; GENE TRANSFER; NEISSERIA GONORRHOEAE; NEW ZEALAND; NONHUMAN; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREDICTIVE VALUE;

EID: 84880110707     PISSN: 11710195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Genco C, Wetzler L (Editors). Neisseria: Molecular Mechanisms of Pathogenesis. Caister Academic Press, Norfolk, England, 2010.
2. Sherris JC (Editor). Medical Microbiology: An Introduction to Infectious Diseases (2nd edition). Elsevier Science Ltd., New York, USA, 1990.
3. Robinson A. Chlamydia trachomatis-the case for screening. In: Moss TR, ed. International Handbook of Chlamydia (2nd edition). Euromed Communications Ltd., England, 2006.
4. Biais N, Ladoux B, Higashi D, So M, Sheetz M. Cooperative retraction of bundled type IV pili enables nanonewton force generation. PLoS Biol 2008; 6: e87.
5. Anderson MT, Seifert HS. Opportunity and means: horizontal gene transfer from the human host to a bacterial pathogen. MBio 2011; 2: e00005-e00011.
6. Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Mort Wkly Rep 2007; 56: 332-336.
7. Kirkcaldy RD, Bolan GA, Wasserheit JN. Cephalosporinresistant gonorrhoea in North America. JAMA 2013; 309: 185-187
8. Ministry of Health. Chlamydia Management Guidelines. Ministry of Health, Wellington, New Zealand, 2008.
9. Lawton BA, Rose SB, Bromhead C, Gaitanos LA, MacDonald EJ, Lund KA. High prevalence of Mycoplasma genitalium in women presenting for termination of pregnancy. Contraception 2008; 77: 294-298.
10. Upton A, Bromhead C, Whiley DM. A Neisseria gonorrhoeae false-positive result using the Roche cobas® 4800 CT/NG assay, New Zealand 2012. J Clin Microbiol 2013; in press.
11. Schachter J, Chernesky MA, Willis DE, Fine PM, Martin DH, Fuller D, et al. Swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005; 32: 725-728.
12. Wiesenfeld HC, Heine RP, Rideout A, Macio I, DiBiasi F, Sweet RL. The vaginal introitus: a novel site for Chlamydia trachomatis testing in women. Am J Obstet Gynaecol 1996; 174: 1542-1546.
13. Miller A, Bromhead C, Jones M, Tustin P. Mucus digestion improves the detection of Chlamydia trachomatis and Neisseria gonorrhoeae on the cobas 4800. Sex Transm Dis 2012; 39: 733-734.
14. Whiley DM. General comments: molecular diagnostics Neisseria gonorrhoeae. RCPA Quality Assurance Programs Pty Ltd., 2012: 2.
15. Centres for Disease Control and Prevention (CDC). Neisseria gonorrhoeae with reduced susceptibility to azithromycin-San Diego, California, 2009. MMWR Mort Wkly Rep 2009; 60: 579-581.
16. Centres for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Mort Wkly Rep 2012; 61: 590-594.
17. Centres for Disease Control and Prevention (CDC). HIV prevention through early detection and treatment of other sexually transmitted diseases-United States recommendations of the Advisory Committee for HIV and STD Prevention. MMWR Mort Wkly Rep 1998; 47: 1-24.